KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Harrington, Kevin Joseph, Rischin, Danny, Greil, Richard, Soulieres, Denis, Tahara, Makoto, Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Åse, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Zhang, Yayan, Gumuscu, Burak, Swaby, Ramona F., Burtness, Barbara
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
An unexpected zoonosis: pulmonary dirofilaria infection mimicking pulmonary neoplasm
Maxwell, Gordon, Sood, Jaideep, Allpress, Stephen
Published in Respirology case reports (01.11.2019)
Published in Respirology case reports (01.11.2019)
Get full text
Journal Article
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Rischin, Danny, Harrington, Kevin J., Greil, Richard, Soulieres, Denis, Tahara, Makoto, de Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Ase, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Zhang, Yayan, Jin, Fan, Gumuscu, Burak, Burtness, Barbara
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients
Fong, Lawrence, Forde, Patrick M., Powderly, John D., Goldman, Jonathan Wade, Nemunaitis, John J., Luke, Jason John, Hellmann, Matthew David, Kummar, Shivaani, Doebele, Robert Charles, Mahadevan, Daruka, Gadgeel, Shirish M., Hughes, Brett Gordon Maxwell, Markman, Ben, Riese, Matthew John, Brody, Joshua, Emens, Leisha A., McCaffery, Ian, Miller, Richard Alan, Laport, Ginna
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Efficacy and safety of the ALK inhibitor alectinib in ALK + non-small-cell lung cancer (NSCLC) patients who have failed prior crizotinib: An open-label, single-arm, global phase 2 study (NP28673)
Ou, Sai-Hong Ignatius, Ahn, Jin Seok, De Petris, Luigi, Govindan, Ramaswamy, Yang, James Chih-Hsin, Hughes, Brett Gordon Maxwell, Lena, Hervé, Moro-Sibilot, Denis, Bearz, Alessandra, Ramirez, Santiago Viteri, Mekhail, Tarek, Spira, Alexander I., Zeaiter, Ali Hassan, Bordogna, Walter, Balas, Bogdana, Golding, Sophie, Morcos, Peter N., Kim, Dong-Wan
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Clinical utility and tolerability of linagliptin in diabetic patients
Maxwell, Lauralee Gordon, McFarland, M Shawn
Published in Drug, healthcare and patient safety (01.01.2013)
Published in Drug, healthcare and patient safety (01.01.2013)
Get full text
Journal Article
Evaluating the prognostic significance of significant weight loss in patients with stage III non-small cell lung cancer (NSCLC) undergoing definitive chemoradiation (CRT) after FDG-PET staging
Senko, Clare, Moore, Julie, Hay, Karen, Lwin, Zarnie, Pratt, Gary, Fong, Kwun, Hughes, Brett Gordon Maxwell
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study
Muñoz Couselo, Eva, Hughes, Brett Gordon Maxwell, Mortier, Laurent, Grob, Jean-Jacques, Gutzmer, Ralf, Roshdy, Osama, Gonzalez Mendoza, Rene Lazaro, Schachter, Jacob, Arance, Ana Maria, Grange, Florent, Meyer, Nicolas, Joshi, Abhishek Jagdish, Billan, Salem, Ojavee, Sven Erik, Yuan, Jianda, Gumuscu, Burak, Bratland, Åse
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: De-Squamate
Ladwa, Rahul, Lee, Jenny HJ, Porceddu, Sandro V, McGrath, Margaret Louise, Cooper, Caroline, Liu, Howard, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle K., Clark, Jonathan, Le, Dieu, Pauley, Marketa, Gonzalez-Cruz, Jazmina, Frazer, Ian, Hughes, Brett Gordon Maxwell, Panizza, Benedict J
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study
Shrestha, Prajwol, Ladwa, Rahul, Heller, Gillian, Low, Tsu-Hui (Hubert), Palme, Carsten, Shannon, Kerwin Frank, Briscoe, Karen P., Hayat, Faisal, Clark, Jonathan, Gupta, Ruta, Hughes, Brett Gordon Maxwell, Lee, Jenny HJ
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Psychosocial impacts of COVID-19 on oncology workforces: Metro versus regional Australia
Ahern, Elizabeth Stephanie, Gasper, Harry Michael, Chan, Bryan, Roberts, Natasha Anne, Hughes, Brett Gordon Maxwell, Wyld, David, Kennedy, Glen, Eastgate, Melissa A., Lwin, Zarnie
Published in Journal of clinical oncology (10.10.2020)
Published in Journal of clinical oncology (10.10.2020)
Get full text
Journal Article
Emotional impact of COVID-19 preparations on metro and regional cancer workforces in Queensland Australia: "We are all in this together "
Roberts, Natasha Anne, Chan, Bryan, Ahern, Elizabeth Stephanie, Gasper, Harry Michael, Kennedy, Glen, Hughes, Brett Gordon Maxwell, Wyld, David, Eastgate, Melissa A., Lwin, Zarnie
Published in Journal of clinical oncology (10.10.2020)
Published in Journal of clinical oncology (10.10.2020)
Get full text
Journal Article
Preoperative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC) (POPCORN)
Ahern, Elizabeth Stephanie, Cubitt, Annette, Ballard, Emma, Teng, Michele W.L., Dougall, William C., Smyth, Mark J., Hughes, Brett Gordon Maxwell
Published in Journal of clinical oncology (10.03.2019)
Published in Journal of clinical oncology (10.03.2019)
Get full text
Journal Article
Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)
Dingemans, Anne-Marie C., Syrigos, Konstantinos, Livi, Lorenzo, Paulus, Astrid, Kim, Sang-We, Chen, Yuanbin, Felip, Enriqueta, Griesinger, Frank, Ohashi, Kadoaki, Zalcman, Gerard, Hughes, Brett Gordon Maxwell, Sorensen, Jens Benn, Blais, Normand, Ferreira, Carlos G. M., Lindsay, Colin R, Dziadziuszko, Rafal, Ward, Patrick J., Obiozor, Cynthia Chinedu, Wang, Yang, Peters, Solange
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R)
Forde, Patrick M., Nowak, Anna K., Hughes, Brett Gordon Maxwell, Kok, Peey Sei, Brown, Chris, Sun, Zhuoxin, Anagnostou, Valsamo, O'Byrne, Ken, Yip, Sonia, Cook, Alistair, Lesterhuis, Willem Joost, Pavlakis, Nick, Brahmer, Julie R., Kindler, Hedy L., Tsao, Anne S., Zauderer, Marjorie Glass, Ramalingam, Suresh S., Stockler, Martin R.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC)
Voss, Martin H, Hotson, Andrew N., Willingham, Stephen, Hughes, Brett Gordon Maxwell, Merchan, Jaime R., Fong, Lawrence, Chu, Michael, George, Saby, Munneke, Brian, Mobasher, Mehrdad, Miller, Richard A.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article